Bradley Pharmaceuticals
This article was originally published in The Tan Sheet
Executive Summary
Enters into an agreement with Syntex to acquire the trademark rights, manufacturing equipment and technical knowledge necessary to produce Carmol 10, an OTC total body dry skin treatment. Carmol 10 will be marketed through Bradley subsidiary Doak Dermatologics